Basic Science For Anaesthetists
Basic Science For Anaesthetists
Basic Science For Anaesthetists
This is a revised edition of a book originally titled Anaesthetic Data Interpretation. The
new title better reflects the contents of the book, which contains additional chapters relevant to the Primary FRCA examination. New topics covered include the ventilatory
response to oxygen and carbon dioxide, which is now a core knowledge requirement,
new concepts in cardiovascular physiology, receptor types and the molecular actions
of anaesthetics. Some of the revisions reflect advances in technology; for example, the
uses of the capnograph and the oxygen analyser have advanced considerably in recent
years. The aim is to provide a concise and understandable review of the physics,
mathematics, statistics, physiology and pharmacology of anaesthesia. Basic Science for
Anaesthetists is a concise and informative text, which will be invaluable for trainee
anaesthetists and an aid to teaching for the trainers.
S Y L V A D O L E N S K A qualified from Charles University, Prague, trained as an anaesthetist in the UK and is currently Consultant Anaesthetist at William Harvey Hospital,
Ashford, Kent. She has also acquired the KSS Deanery Certificate in Teaching. Her
other key professional interests are airway management and obstetric anaesthesia.
Cambridge University Press has no responsibility for the persistence or accuracy of urls
for external or third-party internet websites referred to in this publication, and does not
guarantee that any content on such websites is, or will remain, accurate or appropriate.
Every effort has been made in preparing this publication to provide accurate and up-todate information which is in accord with accepted standards and practice at the time of
publication. Although case histories are drawn from actual cases, every effort has been
made to disguise the identities of the individuals involved. Nevertheless, the authors,
editors and publishers can make no warranties that the information contained herein is
totally free from error, not least because clinical standards are constantly changing through
research and regulation. The authors, editors and publishers therefore disclaim all liability
for direct or consequential damages resulting from the use of material contained in this
publication. Readers are strongly advised to pay careful attention to information provided
by the manufacturer of any drugs or equipment that they plan to use.
To my husband
CONTENTS
List of abbreviations and symbols
List of figure captions
Forewords
Preface
Preface to the second edition
page xi
xiii
xvii
xxi
xxiii
1
2
4
8
14
18
22
7. Mathematical concepts
26
30
36
40
44
48
54
16. T-pieces
60
62
52
58
67
68
72
76
vii
Contents
80
5. Capnography
86
92
96
100
102
104
109
114
116
118
122
124
7. Coronary circulation
128
viii
110
133
134
136
142
4. Ventilationperfusion relationship
146
152
156
160
162
165
1. Drug elimination
166
170
174
180
182
Index
191
Contents
Part 4: Pharmacology
186
ix
C
degrees Celsius
d
distance (m)
d
rate of change (derivation)
D
diameter (m)
e
base of natural logarithms
E
extinction coefficient
F
force (kg m per s = N)
g
gram
I
light or current intensity (Cd or A)
J
joule
K or k constant
K
kelvin
l
length (m)
l
litre
m
metre
mol
amount of substance that contains as many elementary particles as
there are atoms in 0.012 kg carbon-12
n
number
N
newton
P
power (J s-1 = W)
p
pressure (Pa ); see chapter on gas pipeline pressure for other units
and their conversion
Pa
pascal
Q
electric charge (C)
Q
flow (l s-1 ) (also denoted as dV/dt)
r
radius (m)
R
resistance (Pa l-1 per s)
R
universal gas constant
Re
Reynolds number (dimensionless)
STP
standard temperature and pressure (0 C, 1 atmosphere = 273 K,
101.3 kPa)
t
time (s)
xi
T
v
V
W
W
Greek symbols
(eta)
(mu)
(pi)
(ro)
(sigma)
(capital sigma)
(tau)
(zeta)
viscosity
population mean
3.141592653 . . .
density
population standard deviation (SD)
summa = total
time constant
damping
FIGURE CAPTIONS
Part 1
1. Three gas laws: Boyles, Charles and Gay-Lussac.
page 3
2. Avogadros hypothesis.
3
3. Isothermic compression.
5
4. Adiabatic decompression.
7
5. Laminar flow as the product of area and velocity. The influence of
doubling the radius on flow.
9
6. Laminar flowpressure relationship.
11
7. Laminar flowresistance relationship.
11
8. Turbulent flowdriving pressure relationship.
13
9. Turbulent flowresistance relationship.
13
10. Latent heat of vaporization of water.
15
11. Latent heat of vaporization of nitrous oxide.
15
12. Water vapour content (absolute humidity) of air fully saturated
with water, as a function of temperature.
17
13. Force as a product of pressure and area.
19
14. Pressure generated in different size syringes with constant force.
19
15. Pressure-reducing valve.
21
16. Work as the product of force and distance.
23
17. Work (energy) as the product of pressure and volume.
23
18. Power as a derivative of work; cardiac power at two levels of
inotropy.
25
19. Cardiac power as a product of force and velocity.
25
20. Cardiac power as a product of pressure and flow.
25
21. Linear relationship.
27
22. Reciprocal relationship the rectangular hyperbola.
27
23. Square function parabola.
29
24. Sine waves and their addition.
29
25. Exponentials: (a) exponential growth curve. (b) growth of bacteria
with time.
31
26. Exponentials: (a) exponential decay curve. (b) exponential decline
plasma remifentanil concentration.
31
27. Exponentials: (a) saturation exponential curve.
(b) lung filling with a constant pressure generator.
33
28. Logarithmic curve and exponential growth curve.
33
29. Exponentials: rate of decay, time constant.
37
30. Area under the exponential curve.
39
31. Normal distribution of height in adult men.
41
32. Gaussian distribution blood glucose measurements in a large
normal sample.
41
xiii
xiv
43
43
43
45
45
45
47
47
47
49
51
53
55
55
57
59
59
61
61
63
65
69
69
69
71
73
75
75
75
77
77
79
81
83
83
85
87
87
89
91
91
93
95
97
97
99
99
99
101
103
105
105
107
107
Part 3a
87. Intravascular pressure waveforms on the right side of the heart
during pulmonary artery catheterization.
111
88. Arterial blood pressure and respiratory swing.
113
89. Arterial blood pressure and pulse during the Valsalva manoeuvre. 115
90. FrankStarling curves.
117
91. Left ventricular and diastolic pressurevolume relationship.
119
92. (a) Left ventricular pressurevolume loop at steady state;
(b) The effect of increased inotropy on left ventricular
pressurevolume loop. (c) The effect of left ventricular failure
(reduced inotropy) on left ventricular pressurevolume loop.
121
93. Classes of haemorrhage.
123
94. Cerebrovascular autoregulation.
125
95. Cerebral elastance curve.
125
96. Autoregulation of cerebral blood flow within physiological limits. 127
97. Cerebral blood flow as a function of arterial carbon dioxide tension
127
(paCO2 ) and oxygen tension (paO2 ).
98. Coronary artery flow and arterial blood pressure.
129
99. Coronary autoregulation.
129
100. Effect of inhalational anaesthesia with halothane on coronary blood
flow and myocardial oxygen consumption.
131
xv
Part 3b
101. Oxyhaemoglobin dissociation curve.
102. Respiratory mechanics. (a) resting position, (b) pressure gradients
after a tidal breath.
103. Static compliance.
104. The effect of age on lung and chest wall compliance.
105. Changes in closing volume (CV) and functional residual capacity
(FRC) during adulthood.
106. Size of airway and total cross-sectional area.
107. Airway resistance and age.
108. Dynamic compliance loops during spontaneous respiration.
109. Lung pressurevolume diagram in a young, healthy adult.
110. Alveolar volume in relation to distance from lung apex.
111. Diagram of the West zones of the lung.
112. Schematic drawing of ventilationperfusion relationship in the
three zones of the lung.
113. The oxygen cascade.
114. The effect of shunt function and inspired oxygen fraction
(fio2 ) on arterial oxygen (Pa O2 ).
115. Gas R line.
116. Ventilatory response to oxygen.
117. Ventilatory response to carbon dioxide.
Part 4
118. First-order kinetics of remifentanil and alfentanil.
119. Zero order and first order elimination of blood alcohol.
120. Biexponential decline in plasma concentration of a drug after
intravenous injection in a two-compartment model.
121. Factors influencing alveolar gas or vapour concentration during
uptake.
122. Rate of rise of alveolar concentration for different anaesthetic
agents.
123. Drug dose and effect.
124. Opioid drugs log doseresponse curves.
125. Competitive and non-competitive antagonism of norepinephrine.
126. ED50 , LD50 .
127. MAC and lipid solubility of volatile agents in 100% oxygen and in
66% nitrous oxide.
128. Multisubunit ligand-gated ion channel.
129. G-protein coupled receptor.
130. Receptor as enzyme.
131. Drug levels in three compartments after a short infusion.
132. Drug levels in three compartments after a prolonged infusion.
133. Plasma alfentanil concentration after short and long infusion.
134. Context-sensitive half-time after short infusion.
135. Context-sensitive half-time after prolonged infusion.
xvi
135
137
137
139
141
143
143
145
147
147
149
151
153
155
157
161
163
167
167
169
171
173
175
177
179
179
181
183
183
185
187
187
189
189
189
FOREWORD
The syllabus for the Primary FRCA examination is broad, covering basic
anaesthesia and associated skills together with an in depth knowledge of the
principles of basic science which underlie clinical practice. Added to this,
is the requirement to pass the examination at an early stage of the trainees
career. Often, it is an inadequate understanding or wariness of concepts which
involve physics or simple mathematics that is the impediment to success in
the examination.
The author has written a book which explains the principles of physics,
mathematics and statistics and applies many of them to an understanding of
anaesthetic apparatus, clinical measurement, cardiovascular and respiratory
physiology, and general pharmacology. Each concept is supported by a graph
or diagram which is explained in the text. A graphical display of data or a
good diagram is often the key to interpretation and conveying a thorough
understanding of subject matter to an examiner. This approach applies equally
when responding to a question in an oral examination or when supplementing
a written answer.
This book is undoubtedly aimed at the candidate sitting the Primary examination, however, the Final FRCA candidate should not forget that the theme
of questioning in the second oral examination is basic science applied to anaesthesia, intensive care and pain management. This book should not be regarded
as a substitute for the standard textbooks but will be invaluable as a supplement and also for revision. Senior colleagues will find in this book a concise
refresher course on basic science principles that will be of personal value and
will assist in teaching trainees. A proportion of candidates fail the oral section
of an examination having done well in the written part. This would suggest
they have the knowledge but fail in their verbal presentation. There is a fund
of questions, diagrams and graphs in this book that can form the basis of mock
vivas for candidates to improve their fluency of presentation in preparation
for the examination proper.
Leslie E. Shutt
Bristol
January 2000
xvii
FOREWORD
The successful and safe practice of anaesthesia depends, amongst other things,
upon a good comprehension of the scientific foundations of the subject. It is
for this reason that all examining boards set scientific questions in various parts
of their examinations, whether in conventional multiple choice or single best
answer format, formal essays, short answers, OSCEs (objective structured
clinical examinations) or in the oral examinations. Candidates have much
more difficulty with the basic and applied science sections of the examination
than with any other parts. In particular, the understanding of physics and the
application of physical principles are not easy. Many candidates, quite frankly,
lack basic education in these topics when starting at medical school; moreover,
they are less easy to learn as one grows older, especially when embarking on
a busy clinical career in anaesthesia.
I can remember from my own experiences as a candidate for the Primary
FRCA (then called the FFARCS) a legendary examiner who would push a
sheet of paper over to the unfortunate candidate during a viva and invite him or
her to draw the structure of pethidine (merperidine, Demerol). Thank goodness that does not happen nowadays, but reliance on the production of drawings or graphs to illustrate a point is very common, for indeed a good picture is
worth a thousand (some say ten thousand) words. The interpretation of radiographs and electrocardiograms has stood the test of time. Moreover, many
examiners now rely upon previously produced drawings or photographs of varying clarity and quality - as part of the examination, and I must confess
that I have produced some of my own over the years.
Sylva Dolenska originally intended to use the apt subtitle do you get the
picture? for this book but it was changed to Anaesthetic Data Interpretation and
the Primary FRCA examination became her target. Nevertheless, success
in any examination in anaesthesia, wherever in the world, relies upon the
grasp and understanding of basic scientific facts. Hence her approach of using
illustrations (linked to explanations) that have almost come straight from
the examiners briefcase provides welcome help for candidates. Examples are
drawn from everyday clinical anaesthesia: the use of medical gases, respiratory and circulatory physiology, the behaviour and distribution of drugs, and
concluding with concepts of receptors. Many current and future candidates
for examinations in anaesthesia should be grateful for the help this will give
them.
Anthony P. Adams
Professor of Anaesthetics in the University of London at the Guys, Kings and
St. Thomas School of Medicine, Kings College, London.
January 2000
xix
PREFACE
There are many textbooks to chose from when preparing for the FRCA
examination; the candidate suffers not from lack of information but rather
from being inundated with it. The candidate then has the task of information
sorting and data compression to memorize and utilize all this information.
Graphic representation of data is an excellent form of data compression; figures or drawings are frequently asked about at the viva examination, particularly since the candidates understanding of a problem comes across most
clearly when drawing a figure or a using a picture. For anaesthetists whose first
language is not English, figures are also a good way of approaching a topic
I certainly find it easier to find words when describing a plot.
I constructed parts of this book when revising for the Primary Examination and afterwards when preparing tutorials. The book differs from most
in that the text accompanies the pictures, rather than the pictures complementing the text. In many cases, the text is simply a legend to the figure or diagram, expanded by background information. For this reason, the
figures are described only by the names of the axes and their units along
with identification of any other important lines and symbols. The layout
each page of text opposite the relevant figure(s) conveys the essential link
between picture and text, and I hope it makes orientation and understanding
easier.
Not all knowledge required for the FRCA (Primary or Final) is suitable
for graphical representation. The properties of anaesthetic drugs, for instance,
lend themselves to tabulation rather than to diagrammatic representation,
and they require little in the way of understanding of fundamental concepts. I
therefore recommend the reader to read basic, comprehensive textbooks before
beginning this text because, first, this book is not intended as comprehensive
and, second, because a complete textbook will give a fuller perspective on the
topics represented.
The book was updated according to the latest FRCA syllabus, and it
shows the relevance of basic science to clinical anaesthesia in practical examples throughout. A choice had to be made, however, even among the topics suitable for illustration. Most of the topics I have chosen rank highly
in order of importance to anaesthetists (Jones, Anaesthesia (October 1997),
930). Descriptive statistics and mathematical concepts, although not popular, are included as they appear in the syllabus and because they constitute
the basic knowledge on which the candidate can build an understanding of
other subjects seen as more relevant to anaesthesia (such as the principles of
measurement).
Although the book is intended mainly for the Primary FRCA candidate,
it would also make an excellent aide-memoire for clinical tutors and all
xxi
Preface
xxii
xxiii
Part 1
Physics, mathematics,
statistics, anaesthetic
apparatus
1
Part 1
Part 1
Forces of adhesion in the gas lessen the impact on the container. The result
is that the pressure measured is less than that predicted by the universal gas
equation. The effect is magnified in a smaller volume.
Also, the molecules are not negligible in size; their total volume lessens
the volume of the container, decreasing the distance of travel; a correction for
the volume of the molecules (Vo ) has to be applied.
When gas is compressed at a sufficiently low temperature, the forces of
adhesion eventually cause its liquefaction (i.e. the forces of attraction overcome the random thermal motion).
Isothermic compression decompression
Figure 3 shows slow compression of nitrous oxide under various temperature
conditions. Because compression is slow, there is sufficient time for temperature equilibration with the surroundings. This pressurevolume change is
called isothermic.
The top isotherm for 50 C behaves as an ideal gas isotherm. At 36.5 C the
isotherm just touches the lightly shaded area in the graph, which represents
the gas and liquid phase. This temperature is the critical temperature of
nitrous oxide, above which the gas cannot be liquefied at any pressure. At
lower temperatures, here 20 C, the gas can be liquefied. If compression is
slow to allow temperature to remain constant, the pressure in the container
remains constant until all gas is liquefied: the decrease in volume of the
container is matched by a decrease in volume of the gaseous phase (which is
now called vapour) as it is being liquefied. The space above the liquid phase is
saturated with the vapour, and the pressure inside the container at the given
temperature is the saturated vapour pressure (which is constant at a given
temperature).
Once the total contents are liquefied, and if compression is continued, the
pressure inside the container rises steeply, as liquids are virtually incompressible. Slow decompression would follow the same isotherm in the opposite
direction.
The phenomenon of liquefaction is used in practice to increase the amount
of substance in a container: nitrous oxide can be liquefied at ambient temperature in a moderate climate (but not in the tropics); by contrast, oxygen,
with a critical temperature of 119 C, has to be liquefied in special insulated
vessels to prevent its warming.
1
Real gas compression
50
1
Part 1
6
1
Real gas compression
Part 1
Flow is defined as the volume of gas or liquid passing a cross sectional area
per unit of time. If the volume in a cylinder (or a large tube) is given by the
product of its area and length, then the flow in this tube can be thought of as
area multiplied by the velocity (see Figure 5):
V = A.
Q = dV/dt = A.d/dt = A.v
(equation 1)
Laminar flow
In laminar flow the fluid moves in a steady manner without eddies or turbulence. A slowly flowing river in a straight stretch is a good approximation.
You may notice that the flow near a river bank is very slow while in the centre
it is the fastest. This is because of frictional forces between the flow and the
side. The speed, or velocity, is therefore related to the distance from the side.
In fact it can be shown that the maximum velocity is directly proportional
to the square of the radius; mean velocity is half the maximum velocity
(
v = v max /2).
The following are factors affecting the flow velocity:
r Square of the radius, as mentioned above.
r Pressure gradient between the beginning and the end point (a
mountain river with a steeper gradient flows much faster than a river near
the sea where the gradient is less).
r Viscosity: we know from experience that more viscous fluids (e.g. oil)
flow more slowly than less viscous fluids (e.g. water). Viscosity in physics
is denoted by the Greek (eta).
r Length of the tube: friction slows down the flow at the sides of the tube.
The longer the tube, the longer acting the frictional force becomes and
the slower the flow.
Mathematically expressed:
v r2
v P
v 1/
v 1/.
From equation 1, this equation has been derived for laminar flow:
= A.
Q
v
where
Pr 2
(the factors above and a numerical factor of 8 are
8
not derived here)
v =
8
A1
V2
V1
r2
r1
A2
Figure 5. Laminar flow as the product of area and velocity. The influence of doubling
the radius on flow.
and
A = r 2 .
Part 1
(equation 2)
10
1
Flow and resistance
s per
11
Turbulent flow
Part 1
12
1
Flow and resistance
--1
Figure 8. Turbulent flow: driving pressure is the square function of target flow.
sper
13
1
Part 1
14
Wa
Figure 10. Latent heat of vaporization of water. Reproduced with permission from
Butterworth-Heinemann.
Figure 11. Latent heat of vaporization of nitrous oxide. Reproduced with permission
from Butterworth-Heinemann.
15
1
Part 1
Humidification requires addition of latent heat. During inhalation, ambient air is warmed and humidified in the upper airway; latent heat must be
supplied for this. During exhalation, the expired gas is cooled in the upper
airway and some, but not all, of the heat and water is returned to the nasal
mucosa. Because ambient air is usually cooler and less humid than expired
air, water and heat from the body are lost during breathing (about 250 ml
water and 350 calories per day). The biggest part of heat thus lost is the latent
heat of vaporization.
The amount of vapour present in air is limited by temperature. When air
contains the maximum amount of vapour, it is said to be saturated by it.
Figure 12 shows the relationship between temperature and the maximum
amount of water vapour in the air. The shape of the line is a parabola but note
that it does not go through zero on the y-axis. Notice that at 20 C, the air
contains a smaller mass of water than at 37 C.
Vaporization
Anaesthetic vaporizers are designed to produce a concentration of anaesthetic
vapour that corresponds to the vaporizer setting regardless of gas flow passing through them. The gas in the vaporizer chamber is fully saturated with
anaesthetic vapour, but the amount of vapour depends on temperature, as
shown above: as the anaesthetic vapour is removed from the vaporizer chamber by the dry gases, latent heat is removed from the remaining liquid and the
vaporizer walls. Unless temperature compensation is applied, the amount of
vapour and its saturated vapour pressure would drop, as would the vaporizer
output. Modern vaporizers have several sophisticated methods of temperature compensation, based on a temperature-controlled valve which adjusts
the splitting ratio: as temperature inside the vaporizer decreases, more gas is
allowed to pass through the vaporizing chamber to compensate for the loss of
saturated vapour pressure. At 20 C saturated vapour pressure of desflurane is
higher than that of most agents. However, because of its low lipid solubility,
it has a fairly high minimum alveolar concentration. The vaporizer, therefore,
has to be heated to produce sufficient amounts of vapour.
16
1
Heat, vaporization and humidification
Figure 12. Water vapour content (absolute humidity) of air fully saturated with
water, as a function of temperature. Reproduced with permission from ButterworthHeinemann.
17
1
Part 1
18
1
Simple mechanics 1: mass, force, pressure
p
A:F = p2 A2
P2
B:F = p1 A1
P1
A1
A2 A
Figure 13. Force as a product of pressure and area; reciprocal relationship between
pressure and area for constant force.
Q ~ P1
Q ~ P2
A1
A2
st.)
st.)
Figure 14. Pressure generated in different size syringes with constant force.
19
1
Part 1
20
In anaesthetics, the principle of balancing forces is used in pressure reducing valves, where high and low pressure gas push against a large area of a
diaphragm connected to a rod, as shown in Figure 15. The sum of these
forces is opposed by the tension of a spring attached to the other side of the
diaphragm. This is set slightly above the force of the high pressure gas acting
on the rod. When low gas pressure decreases, the tension of the spring overcomes the forces produced by the gas and the rod is pushed out, opening the
high pressure gas inlet. Low pressure then rises sufficiently inside the valve
to overcome the tension of the spring and high pressure gas inlet is shut, and
the cycle is repeated as low pressure gas escapes.
1
Simple mechanics 1: mass, force, pressure
21
1
Part 1
22
First low (the law of conservation of energy) and second law of thermodynamics, which
deals with entropy, are beyond the scope of this book.
1
Simple mechanics 2: work and power
F (N)
l1
F1
F2
l2
l2
l1
Figure 16. Work as the product of force and distance; reciprocal relationship of force
and distance for constant work.
p
A: E = P1.V1
P1
B: E = P2.V2
P2
V1
V2
Figure 17. Work (energy) as the product of pressure and volume, reciprocal relationship
of pressure and volume for constant energy.
23
1
Part 1
Power is the rate at which work is done: P = dW/dt . The unit is 1 watt
(W), equal to 1 J s1 . Unfortunately, the symbol for work and for the unit of
power is the same letter (W). The symbol d means change, or derivative, that
is what increment in work was done in a given time. Derivatives are dealt with
in more detail in the chapter on flow measurement. Notice that whilst work
has a lot to do with force, time becomes an important factor when dealing
with power.
If the force used in some work is constant, by substituting the product F.l
for work we obtain:
P = F.dl /dt = F.v (in words, power is the product of force
and velocity).
Imagine a pump worked at a constant pressure to shift fluid, then by substituting pressure and volume for work we obtain P = dW/dt = pdV/dt = p.Q
(in words, power is the product of pressure and flow. From the above
formulae, it can be seen that there are three ways of expressing power. Applied
to the heart muscle, these will be:
r power as the slope of the work curve against time (see Figure 18). If
cardiac work is plotted against the systolic ejection time, the slope of the
resulting line is steeper for the heart driven by inotropes. Note that the
plot would resemble the Starling curve but the parameters are different.
r power as the product of force and velocity: this is relevant to the
isolated papillary muscle preparation. The force of its contraction
and the velocity of the contraction, as measured in the experimental
situation, define the power. Initially, the muscle is stretched to a starting
tension Fo , and the velocity is zero. The muscle is then stimulated and as
it contracts, the passive stretch is lost and velocity increases. In Figure 19,
muscle shortening velocity is plotted against the initial passive stretch
(tension). Papillary muscle power, the product of the force and velocity of
contraction is the shaded area under the force-velocity line. The
force-velocity line is an approximation; force and velocity of contraction
are reciprocally related i.e. the line should in theory by a rectangular
hyperbola. The graph shows how the area would increase with increased
preload (greater initial stretch, higher initial tension but the same
maximum velocity), and with increased inotropy (higher initial tension
and higher maximum velocity, much higher power).
r power as the product of pressure and flow: cardiac power is then a
product of mean blood pressure and cardiac output (see the relevant
chapter). Under normal conditions blood pressure and cardiac output are
directionally proportional to each other (assuming the aortic impedance Z
is constant). In Figure 20 the plot of blood pressure as a function of
cardiac output for our purposes is a linear relationship ( p = ZQ). The
slope of this line is the impedance, and the cardiac power is the shaded
area under it. Notice that the x-axis here is not the time axis.
24
Ad
P2
P1
W1
t
W2
W1
Figure 18. Power as a derivative of work; cardiac power at the two levels of inotropy.
He
W2
t
P1
P2
V
gh
rm
ig
Hi
No
al
Power
z
Q
25
Mathematical concepts
Part 1
26
1
y = kx k = 1
Mathematical concepts
y=kx k=2
Axis of
symmetry
k
k
k
x
Figure 22. Reciprocal relationship the rectangular hyperbola.
27
Parabola
Part 1
28
1
Mathematical concepts
k=1
k = 0.5
y
y3 = y 1 + y 2
y1
Ti
y2
29
Part 1
30
1
Exponentials 1: the curves
(a)
(b)
Time
Figure 25. (a) Exponential growth curve. (b) growth of bacteria with time.
(a)
(b)
Time
Figure 26. (a) Exponential decay curve. (b) exponential decline plasma remifentanil
concentration.
31
Part 1
The process is reverse of exponential decay, but this time inverted around the
x-axis, and it works against a limiting value. The formula therefore is
y = a b x ,
where a is the limiting value, and the minus sign denotes the change in orientation around the x-axis (Figure 27a). A pure mathematical conversion of
exponential decay would have no limiting value (y = b x ). The curve is
symmetrical with the exponential growth curve across the zero point. Lung
filling during intermittent positive pressure ventilation is depicted in Figure
27b. The exponential coefficient for lung filling is influenced by lung compliance and airway resistance. The larger either of these factors, the slower
the lung filling, and conversely the smaller they are, the faster the lung filling.
Thus the filling rate constant is the inverse value of the product of lung
compliance and airway resistance (1/C.R); their product, the reciprocal of the
filling rate constant (C.R) is the time constant of the process (see below).
Figure 27b represents the formula
Y = 500 (500.et /300 ).
The exponential formula is for convenience multiplied by the limiting value
to obtain 0 for y at the beginning. The negative exponential factor 1/300 in
the formula indicates that lung filling has a time constant of 300 ms.
Logarithm
Logarithm is the exponent to the power of which the base has to be raised
to get the specified number. This complicated definition means that this is
the reverse of exponential growth function (just as square root is the reverse
of square function). Figure 28 resembles superficially saturation exponential, but it is different. The logarithmic curve is symmetrical with the exponential growth curve around the 45 axis, and it asymptotically approaches
(never reaches) the y-axis: a logarithm of zero or negative numbers cannot
be obtained, if the base (10 or e) is a positive number. y has no limit, which
means it reaches infinity in both directions.
By contrast, a saturation exponential is symmetrical with the exponential
decay curve around the x-axis; it asymptotically approaches the horizontal
axis, or a limiting value above it, i.e. y has an upper limit.
32
1
Exponentials 1: the curves
Time
(a)
(b)
Figure 27. (a) Saturation exponential curve, (b) lung filling with a constant pressure
generator.
33
1
Part 1
34
1
Exponentials 1: the curves
35
1
Part 1
36
Exponentials 2: Properties of
exponential decay curve
1. Decrease in constant proportion: in practice this means that the rate of
decrease depends on the mass present. The mass present at any
point is graphically represented by the value of the ordinate (y-axis). The
rate of decay is not constant, it is the proportion of the mass that is
lost that is constant: the previously introduced elimination rate
constant in fact determines this fixed proportion eliminated per unit of
time. For example, when emptying a bath across a fixed resistance (pipe),
the flow rate (of emptying) depends directly on the hydrostatic pressure
(the level of water) that changes as the bath empties, while the diameter
of the pipe determines the proportion of contents that is emptied per unit
of time, i.e. the elimination rate constant.
2. Every section of the curve differs from any other section by scale only:
this follows from the first point: because the units of the y-axis are
different from those of the x-axis (the time axis), the scale of the y-axis
can be arbitrarily chosen. By the same token, any point of an exponential
decay curve can be chosen as a starting point, and the vertical scale can
be expanded if values are very small. In practice, this also means that we
can project back and forward if we know a part of the curve.
3. The slope (tangent) at any point is directly proportional to y (the
ordinate): this is also another way of saying the first point (the slope of
the curve is the rate of decrease).
4. The vertical projection of the slope of the curve on the x-axis is constant.
Properties 1, 2 and 4 are shown in Figure 29. Because the x-axis in
natural processes represents time, is called the time constant. The
time constant was already mentioned as the reciprocal value of the
elimination rate constant. Therefore, this point is also indirectly
connected with the first point: if we say a constant proportion per unit of
time is lost, then the time it takes to lose this proportion must be
constant. Think of the time constant as the time to finish had the rate
of decay been maintained. This relationship holds no matter which
starting value of y is chosen. In the bath analogy, the elimination rate
constant is given by the resistance of the effluent pipe. This resistance is
fixed for a given bath and can only let a certain flow of water through for
a particular pressure. It follows that if the flow through the pipe were
constant (i.e. driving pressure was constant), it would take a certain
amount of time to pass a given volume of water: this time would be equal
to the time constant of emptying by hydrostatic pressure. For different
baths, the higher the resistance the smaller the flow for any given
pressure, and the longer the emptying. In other words, the elimination
rate constant (pipe resistance) and the time constant (time to empty if
initial flow rate were maintained) are reciprocally related ( = 1/k), as
said above. The exponential decay equation can then be written as:
y
t
Figure 29. Rate of decay as a function of the ordinate, time constant as a projection
of the tangent to the curve on the x-axis.
37
1
Part 1
38
Figure 30. Area under the exponential curve equals the area of rectangle
39
Descriptive statistics
Part 1
40
1
Descriptive statistics
Number
t
(m
Figure 32. Gaussian distribution blood glucose measurements in a large normal
sample.
41
1
Part 1
42
Mode
The mode is the most frequent value. In a skewed distribution it will be the
x-axis value at the peak of the curve (note: not the peak value!). Bimodal
distribution, as its name suggests, has two modes, i.e. two most frequent
values.
1
Descriptive statistics
43
Presentation of data
Part 1
44
1
Presentation of data
Figure 36. Pie diagram proportion of nausea and vomiting according to the type of
surgery in a large sample of day surgical patients.
No
Na
Women
n
Men
n
Figure 37. Histogram (bar diagram) incidence of postoperative nausea and vomiting
in men and women after day surgery procedures.
Number
Bl
Figure 38. Frequency histogram.
45
1
Part 1
46
Me
1
Presentation of data
Time
Figure 39. Correlation coefficient = 1.
Me
Time
Figure 40. Correlation coefficient = 0.
Pain
Time
Figure 41. Line drawing with error bars average pain scores after total abdominal
hysterectomy in patients on morphine patient controlled analgesia (o) and on intramuscular morphine on demand ().
47
1
Part 1
48
B
0
C
10
mmol 11
Figure 42. Frequency distribution of tasting blood sugar in normal and diabetic population.
Frequency
49
1
Part 1
50
Figure 43 plots ROC curves, as described above, for various tests. Sensitivity (true positive rate) is plotted on the y-axis against (1 - specificity)
true negative rate on the x-axis. Looking at Figure 1, it is obvious that if there
was no overlap between the two populations tested, the distribution curves
would be completely separated. There would be no false positives and no
false negatives if the cut off point was placed correctly. Testing such ideal
populations with this cut-off point would show a sensitivity and specificity of
1.0. By artificially moving the cut-off point to lie within one or the other population, we would allow either false positives (by moving to the left towards
point B) or false negatives (by moving to the right towards point C). The
ROC plot of this ideal situation is shown in Figure 43 as a thick black line and
is formed by the y-axis and its coordinate at the value of 1.0. The area under
this curve is equal to 1.0 (it is a square equal to the area of the graph).
In real life, as shown in Figure 42, overlap exists and therefore false positives
and false negatives co-exist. For most tests, it makes sense to put the cutoff point at point A the mid-point between the peaks of the distribution
curves, i.e. where both specificity and sensitivity are highest. A test which
discriminates well between the two populations tested produces a good ROC
curve. This is shown as a thin black line, and it will approximate the ideal
described above. The area under the curve will approximate 1.0. In this case,
the test discriminates well between the two populations, and such test would
be a gold standard.
In some circumstances, it may be better to increase sensitivity at the
expense of specificity or vice versa. One such case is prediction of the
difficult airway. It is desirable that every difficult airway is identified as
such (sensitivity of 100%). Because of overlap of normal and difficult, and
because the cut-off point is moved into the normal area (analogous to point
B in Figure 42), one has to accept a high number of false positives normal
airway identified as difficult. In practice no single test fulfils even this criterion
and we have to apply a battery of tests to improve the results.
Figure 43 also shows a straight interrupted line, the diagonal of the area
of the plot. This represents an imaginary test which does not discriminate
between the two popluations tested, i.e. a useless or irrelevant test. Identification of true positives and true negatives in this case is purely by chance.
The area under this line is equal to 0.5 (half of the square). The more a ROC
curve approximates this line, and the area under it 0.5, the less useful the test.
1.0
Sensitivity 1.0
1 specificity
Figure 43. ROC curves.
51
Part 1
52
1
Gas supply and pressure
Fir
Pi
Back
Blow
Posi
V
Figure 44. Pressure/volume relationship in medical gas supply.
53
Part 1
54
Patient
Ex
Fresh
From
FAo2
V N 2o
VF
Figure 46. The effect of nitrous oxide uptake and fresh gas flow in the circle system on alveolar oxygen concentration. Reproduced with permission from ButterworthHeinemann.
55
1
Part 1
56
1
The circle system
(ml/min)
(min)
Figure 47. Uptake of volatile anaesthetic as a function of time. Reproduced with permission from Butterworth-Heinemann.
57
1
Part 1
58
1
The Mapleson A (Magill) breating system
VE
Ti
VF
VD
VA
Ti
Figure 49. Hypothetical pressure and expiratory flow in the Mapleson A system.
59
1
Part 1
60
T-pieces
T-pieces (Figure 50) are geometrically opposite of the Magill system: the
fresh gas flow inlet is near the subject while the expiratory valve or port is
the furthest. E type is a valveless system suitable for spontaneously breathing
subjects only. F type is a paediatric valveless system.
Figure 51 shows theoretical inspiratory gas flow during spontaneous
breathing in a T-piece system. The inspiratory waveform is a sine wave.
Integration of flow (area under the curve) yields volume inspired. This is
again divided into gas that enters alveoli (VA ) and dead space gas (VD ). Superimposed on the graph is the fresh gas flow, which is constant. The area under
the straight line of the fresh gas flow is the fresh gas volume delivered into the
system. It can be seen that at point A the inspiratory flow exceeds the fresh
gas flow. Until that point, excess fresh gas was being deposited in the tubing.
After that point, inspiratory flow is supplied in part (the part exceeding fresh
gas flow) by gas previously deposited in the tubing. Provided that the roughly
triangular area between the fresh gas flow line, the inspiratory curve up to
point A, and the y-axis, which is the volume deposited in the large bore
tubing, equals the area under the peak inspiratory flow above the fresh gas
flow line up to point B (which is the volume of gas drawn from the system
in excess of fresh gas flow during that time), no CO2 -containing gas will
be rebreathed. These conditions will apply if fresh gas flow is approximately
twice the minute volume during spontaneous respiration.
During controlled ventilation, fresh gas flow mixes with expired gas
as the peak ventilatory flows are higher; the inspirate will then contain CO2 .
Under these conditions the magnitude of rebreathing will depend on fresh gas
flow and minute ventilation: an increase in either of these will lower arterial
CO2 tension. In fact, arterial partial pressure of CO2 becomes the product of
fresh gas flow and minute ventilation. To maintain the CO2 level, an inverse
relationship must be maintained between fresh gas flow and minute volume.
If minute ventilation is increased, fresh gas flow can be reduced; this
provides economy of flow during controlled ventilation.
1
T-pieces
VE
VF
VD
VA
Time
Figure 51. Inspiratory flow and fresh gas flow in the Bain system. Reproduced with
permission from Butterworth-Heinemann.
61
1
Part 1
62
PM
PA
Normal lung
Time
Time
Time
(b)
PA
COAD ( Resistance)
Time
Time
Time
PM
(c)
PA
PM
Time
Time
Time
(a)
63
1
Part 1
64
(a)
Normal lung
Time
PM
PA
Time
Time
(b)
COAD (Resistance)
Time
PA
PM
Time
Time
(c)
PM
PA
Time
Time
Time
65
Part 2
Clinical measurement
67
Part 2
68
Re
Re
(b)
Time
Time
Figure 54. Linearity principle: (a) measurement accurate but impercise. (b) measurement precise but inaccurate.
(a)
Re
Re
(a)
(b)
Time
Ti
Figure 55. Drift: (a) baseline (zero) drift. (b) sensitivity drift.
Ou
In
Figure 56. Hysteresis loop.
69
2
Part 2
70
Time
Figure 57. Critical damping ( = 1).
Time
71
2
Part 2
Electromanometers, frequency
response and damping
An electromanometer is a device for direct (invasive) blood pressure measurement. The sensor is a pressure transducer, a device that converts mechanical
energy to electrical signals: blood pressure oscillations are conducted along a
fluid-filled tube (catheter) to a chamber that has a flexible diaphragm on the
end (shown in Figure 58). Displacement of the diaphragm by these oscillations is sensed electrically and converted into an electrical signal.
Frequency response
After a single change in pressure inside the system, the fluid continues to
move in oscillations as it is reflected from the diaphragm on one side and
blood vessel wall on the other. The frequency of this oscillatory movement
is inherent to the set-up and is called the resonant or natural undamped
frequency, fn .
To follow the measured pressure the system must be able to respond
quickly: its frequency response must be higher than the highest frequency
measured.
The frequency response (natural resonant frequency) is calculated using
the formula:
f n = r /2 S/l
It can be seen that a large-bore catheter (large radius r) of short length (l), a
stiff diaphragm (S), plus fluid of low density ( ), are the requirements for a
high natural resonant frequency of an electromanometer.
Damping
For correct operation, the system has to be able to respond adequately to the
highest frequency contained in the transducer waveform. Therefore, it has to
respond quickly. However, a high natural resonant frequency of the system
would produce natural oscillations at that frequency, which could interfere
with the recorded frequency. Damping is the tendency to extinguish natural oscillations through viscous and frictional forces. In the mechanical
model this is provided by immersing a spring in a viscous fluid, which slows
down and extinguishes the natural oscillations. The same factors that influence natural frequency also influence damping but in an inverse manner; in
addition, the viscous resistance, as known from the HagenPoiseuille formula, is directly proportional to viscosity, . In the clinical situation, the
specific fluid viscous resistance and density are constant and can be ignored.
Dextrose is used because it is a non-ionic solution.
72
Catheter
Diaphragm
Blood
vessel
73
2
Part 2
It follows from the above that the factors that we can use to manipulate
the response of the system are catheter length, its diameter and diaphragm
stiffness. Long and narrow catheters reduce the frequency response, and
increase damping.
Figures 57 and 5961 illustrate four situations with different degrees of
damping.
1. In a system where damping is virtually absent ( 0), a stepwise
pressure change results in an overshoot followed by oscillations at natural
frequency. Such a situation would arise if the catheter is relatively wide
and short. In the corresponding arterial blood pressure trace, note the
natural oscillations after a flush and on the trace, and overshoot of the
signal.
2. At the other extreme, if a long and very narrow catheter is used, damping
is greatly increased ( 1), and the system is unable to respond quickly
to the pressure change. The graphic recording is that of a slow-rising
saturation exponential curve. The corresponding blood pressure trace has
a more rounded form with loss of detail; oscillations after flush are
absent. In the extreme case, the pressure trace almost converges on the
mean blood pressure.
3. If we manipulate the parameters in such a way that the system responds
more quickly but just avoids overshooting, damping is said to be critical
( = 1) (Figure 57). Natural oscillation after flush is absent in the
hypothetical arterial blood pressure trace but some loss of detail is still
present.
4. The situation above is clearly not the best solution, as the response of the
system may not be fast enough to follow the higher frequencies.
Therefore, damping is further reduced (catheter shorter and wider,
diaphragm stiffer) to allow a small overshoot. Experimentally it was
found that the best compromise between accuracy and speed is achieved
when damping is two-thirds of critical ( = 0.66): this is optimal
damping (Figure 61). On the arterial blood pressure trace, the small
overshoot is found as a single oscillation after flush, and it can be seen
that detail is preserved without distortion by oscillations. A too damped
trace on the pressure recording may be due to the presence of air, or to
partial blockage of the catheter by clot, resolved by removal of air and by
flushing of the line.
Another factor that can be accidentally or deliberately introduced is an air
bubble: this interrupts the fluid column and in effect reduces the stiffness of
the diaphragm, as air is compressible. The presence of air therefore reduces
the frequency response of the system, and increases damping. See also the
chapter on basic measurement concepts.
74
Time
Time
Time
Time
Time
Figure 61. Optimal damping ( = 0.66).
Time
75
Part 2
76
2
Pulse oximeter principle
Me a
Ox
Re
Ca
SpO2 (%)
A660/A940 (nm)
Figure 63. Relationship between saturation of arterial blood with oxygen and the light
absorbances ratio of haemoglobin.
77
2
Part 2
78
The pulse oximeter detects the cyclical change in light absorption in the
arterial end of the capillaries as well as constant light absorption by venous
blood and tissues. The constant absorption is ignored, and pulse waveform
displayed based on the changing absorption by arterial blood, as shown in
Figure 64.
There are numerous sources of error and interference which include physiological and physical factors (vasoconstriction, hypotension, additional arterial
or venous pulsations, scattering and refraction of light, time delay), intrinsic
and extrinsic factors (other types of haemoglobin, dyes, nail varnish, patient
movement, diathermy, ambient light). Inherent error is less than +/3% at
saturations > 70%.
Pulse oximetry as a form of monitoring has many advantages: it is a continuous non-invasive method of measurement of haemoglobin oxygen saturation,
gives early warning of hypoxic events, and is superior to clinical judgement.
Easy to use, with little interpretation needed, it is one of the minimum monitoring requirements. The main danger is a false sense of security when used
to detect hypoxaemia at high inspired oxygen concentrations.
2
Pulse oximeter principle
79
2
Part 2
Definitions
r Oxygen content: oxygen bound by haemoglobin + oxygen dissolved in
r
r
r
r
80
(b)
Figure 65. Van Slyke apparatus (a) water jacket; (b) mercury levelling bulb. Reproduced
with permission from Butterworth-Heinemann.
(a)
81
Part 2
O2 + 4e + 2H2 O 4(OH) .
The amount of current consumed in the above reaction is directly proportional to the rate of reduction of oxygen at the cathode, and since the
only source of oxygen in the fuel cell was the blood sample introduced, the
ampermeter readout, after electronic integration, will give oxygen content.
Temperature compensation needs to be applied by means of a thermistor.
The fuel cell is a battery and has, therefore, a limited life. External voltage
need not be applied as the battery produces its own. The amount of oxygen
used in the reaction depends on oxygen uptake at the cathode and thus on its
partial pressure. To obtain the oxygen bound in haemoglobin in solution,
oxygen has to be released from haemoglobin. This is done in an apparatus,
called Lex-O2 -Con, by haemolyzing the blood sample with distilled water in
a scrubber and passing oxygen-free carrier gas through it. The carrier gas is
nitrogen with 1% CO. The CO reacts with haemoglobin in a similar manner as ferricyanide in the van Slyke apparatus, i.e. it releases all the oxygen.
Oxygen partial pressure in the carrier gas then directly corresponds to the
concentration in solution as the gaseous and liquid phase are in equilibrium.
Polarographic method: Clark electrode (Figure 66b)
This method uses the same electrochemical reaction as described above. However, no battery is incorporated and therefore an external voltage of 0.6V
must be applied. Note that electrodes are different a platinum cathode and
silver/silver chloride anode. Current flow is then measured which, as in the
case above, depends on oxygen tension at the platinum cathode.
The cathode is protected from deposits by a thin plastic membrane; this
separates it from the blood sample, and blood equilibrates with a small amount
of electrolyte surrounding the cathode. Temperature is again controlled at
37 C.
This method is commonly used in blood gas analysers. The oxygen
electrode must be kept clean and the plastic membrane regularly checked for
deposits or puncture and then replaced.
82
(b)
Figure 66. Oxygen measurement: (a) fuel cell (b) Clarke electrode. Reproduced with
permission from Butterworth-Heinemann.
(a)
83
2
Part 2
to the dumb-bell reflects a light beam and in older versions indicated the
position on a calibrated scale. In the newer null-deflection system two photocells receive the light beam their output is compared and used to generate
a current around the dumb-bell which produces an opposing magnetic field
and thus keeps the dumb-bell in its resting position. This apparatus is very
accurate and fast; it is used in most modern on-line anaesthetic gas analysers
for breath-by-breath analysis.
Mass spectrometry (Figure 68)
This method can be used for measurement of any gas. It separates gases
according to their molecular weight.
A gas sample introduced is ionized and the ions are then separated, based
on their respective charge-to-mass (Q/m) ratio. Only a small amount is
analysed, which diffuses into the system via a molecular leak. Ionization is
achieved by bombarding the sample with electrons. Separating can be done
by means of eliminating all ions except those with a specific Q/m ratio. This
happens in the quadrupole system: the electrical potential across the four
rods is varied so that the ions oscillate as they travel. As the oscillations increase,
the ions hit the rods and lose their charge; only the measured gas is allowed
to travel through. In a sector system, the separating is done by means of
a magnetic field applied across the flow of ions; these are then deflected
according to their Q/m ratio and the deflected beams collected in specific
positions in collector cups.
This instrument allows rapid simultaneous breath-by-breath analysis of
respiratory gases and vapours. It is used in the latest gas analysers. Its cost is
prohibitive for day-to-day use but it is useful for research purposes. Size is
no longer a problem; a portable system has been developed.
In summary, paramagnetic and mass spectrometric methods are suitable
for analysis of respiratory gas mixtures; van Slyke, fuel cell and polarographic
methods are suitable for blood gas analysis.
84
2
Oxygen content and oxygen tension measurement
85
Capnography
Part 2
86
2
CO2
Capnography
CO2
87
2
Part 2
88
2
Capnography
(a)
(b)
(c)
(d)
Figure 71. Abnormalities of single breath curve, (a) chronic obstructive airways disease,
(b) cardiogenic oscillations, (c) dip in plateau, (d) rebreathing.
89
Part 2
90
2
Capnography
%CO2
5
(a)
%CO2
5
0
(b)
Figure 72. (a) Hypercapnia:(a) carbon dioxide overproduction or absorption, (b)
rebreathing.
%CO2
5
(a)
%CO2
%CO2
(b)
(c)
91
Part 2
92
The normal pH range is 7.367.44, i.e. very narrow. pH < 7 is already a severe
acidosis.
When converting [H+ ] to pH, we have to appreciate the properties of the
logarithmic scale. While small changes into the alkaline direction of hydrogen
ion concentration result in significant changes in pH, the reverse happens on
the acid side: between pH 8 and 7, the H ion concentration changes 10-fold,
10100 nmol/l; between pH 7 and 6, the H ion concentration changes 10-fold
again, 1001000 nmol/l, while the pH only lost another unit. Figure 73 shows
this relationship between the pH values of 6 and 8. Bold linear scale on the
x-axis relates to the bold exponential curve. The scale of the logarithmic x-axis
is arbitrarily chosen to fit of [H+ ] 40 and 100.
In practice, pH users know that pH about 6 is an extremely severe metabolic
acidosis, and are not fooled by the seemingly small change in pH. Furthermore, on the alkaline side the physiological consequences of a smaller deviation are equally devastating, i.e. severe metabolic alkalosis, or perhaps more,
since the body is not well equipped to deal with an alkali load (or [H+ ] deficit);
the change on the alkaline side in hydrogen ion concentration from 40 to
10 nmol appears rather small and belies the seriousness of the condition.
A practical way for an approximate conversion of [H+ ] into pH follows
from the properties of the exponential curve: for each 0.3 change in pH
between 7 and 8, halve the hydrogen ion concentration (from 100 at 7 to 12.5
at 7.9); for each 0.3 unit change in pH between 7 and 6, double the hydrogen
ion concentration (from 100 at 7 to 800 at 6.1). The numbers are not exact
because the factor of 0.3 is not exact.
2
[H+ ], pH and its measurement
logarithmic
93
2
Part 2
94
Sample
out
Reference
electrode
Hg/Hg Cl
(calomel)
Ag/Ag Cl
electrode
pH readout
Buffer
solution
Porous plug
Membrane
Water jacket at 37 C
Sample
In
95
2
Part 2
96
Q = p/R
r Variable orifice (and thus resistance), constant pressure. Flow is then
inversely related to resistance or directly related to the size of the
orifice. Laminar flow increases 16 times if the radius of the orifice doubles
(see the chapter on flow). Conversely, flow is reduced 16 times when the
radius is halved and two times if the radius is only 15% less. In Figure 76,
water (rather than gas) flow from a mains pipe with a tap is plotted against
the resistance offered by the tap. It is shown that closing the tap only
slightly from the maximum at point A, to reduce its diameter by 15% at
point B, halves the flow. The Rotameter and the Wright peak flow meter
are examples of variable orifice flowmeters. Constant pressure in the
former is provided by the pressure of the bobbin; the pressure is the ratio
of the product of the mass and gravity over the cross sectional area of the
bobbin (p = F/A = m a/A). The Rotameter is tapered, and thus the
magnitude of the orifice around the bobbin corresponds to the magnitude
of gas flow. In Wrights peak flow meter the opposing pressure is the
tension from a coiled spring acting on the rotating vane area.
r Constant orifice (and resistance), variable pressure. The flow in this
case is directly proportional to the pressure drop (Q = R1 p,
where R = constant), i.e. a linear relationship (Figure 77). The
pneumotachograph is based on this method: a pressure drop across a
gauze screen or a light, plastic valve of known resistance is measured and
transduced. In Figure 75, the relationship between pressure and flow is
illustrated as flow from a vessel with a fixed outlet resistance. The
magnitude of flow at any given moment is directly proportional to the
hydrostatic pressure in the vessel. Pressure is higher at point B on the
plot, and flow is correspondingly higher. (The sequence of events in
practice would be from point B to point A.)
2
(D = 7 mm)
(D = 6 mm)
s per litre)
Figure 76. Reciprocal relationship between flow and resistance for constant pressure.
Q
1
R
p
Figure 77. Linear relationship between driving pressure and flow.
97
2
Part 2
98
Q = dV/dt
Flow as the rate of change of volume with time. d means change or
derivative. Cardiac output by the thermal dilution method uses this formula
(see the next chapter).
It may be helpful to define the derivative and the reverse process, integration at this point. The derivative is the slope of the tangent to the curve
representing a given function. It is described as the rate of change of the
function.
Figure 78 illustrates constant flow as a derivative. Volume of mains water
that passed through the area of interest (the measurement point) is plotted
against time. The flow of water through a pipe under mains pressure is constant, and the rate of rise of volume collected with time is constant: over 1 s,
we collect, say, 100 ml, over 1 min, 6000 ml. When volume against time is
plotted, the slope of this linear relationship is also the slope of the derivative,
the flow. Its numerical value is given by the fraction Vt /t; this is constant at
any point on the line: the flow is constant.
Exponentially falling flow, such as when emptying a bath, is the subject of
the chapter on exponentials.
If we chart flow and wish to know what the volume collected was over a
specified time, integration is applied. Derivation of volume with time yielded
flow; integration of flow, the reverse operation, yields volume. Calculation of
volume from flow is easily done by multiplication of the flow by the specified
time. Mathematically and graphically this is called integration: a small volume
passed in a unit of time can be depicted as the area of a small rectangle with
sides equal to the two variables (unit of time and increment of volume over
time i.e. flow). In Figure 79 the rectangles under the line of flow are the
individual increments. As the flow is constant, it is obvious that the sum of
these incremental rectangles is equal to the total area under the line. If the
flow were variable e.g. decreasing such as in Figure 80, and the incremental
rectangles infinitely narrow, so that the irregularity of the curve at the top
of the rectangle is minimised, their sum would again be equal to the area
under the curve (AUC). To sum up integration with respect to time is
summation of increments over time in order to obtain total.
V
t
V
t
t
Figure 79. Area under the line of flow = volume passed. Constant flow.
V
Q
l over 2 minutes
)
t
Figure 80. Decreasing flow.
99
2
Part 2
100
(a)
Te
(b)
Te
Co
t
Figure 81. Cardiac output measurement (a) high output, (b) low output.
Co
The AUC is identical for the temperature and concentration curves for
a particular cardiac output. Compare the high output graph with the low
output one: the peak of the low output curve is smaller but the total AUC
is larger. This makes sense if we keep in mind that a fast flow will produce
a swiftly rising and falling concentration curve, with a greater instantaneous
change in temperature but a small AUC, while slow flow will do the opposite.
101
2
Part 2
102
P
Figure 82. Pressure changes in constant volume plethysmograph.
103
2
Part 2
104
105
2
Part 2
106
During and after a single breath of oxygen, the change in volume is plotted against time, and simultaneously nitrogen concentration in expired air is
monitored.
In Figure 83, the volume plot against time is shown in the upper half,
and expired nitrogen concentration in the lower half. During inspiration of
oxygen, nitrogen concentration will be zero; it stays at zero while dead space
gas is breathed out. When alveolar gas reaches the measuring point, nitrogen
concentration abruptly rises and stays at a plateau for most of the expiration.
Towards the end of expiration, when closing volume is reached, it rises again,
as more concentrated nitrogen is breathed out from a smaller lung volume.
Dead space volume and closing volume can simply be read from the plot
between the points indicated.
In a patient with emphysema and a high physiological dead space, the alveolar plateau of nitrogen is never reached nitrogen concentration continues
to increase from the beginning of expiration until the end.
2
Lung volumes and their measurement
V
V
Sp
Figure 86. Single breath nitrogen washout. Reproduced with permission from
Butterworth-Heinemann.
107
Part 3a
Physiology: the
cardiovascular system
109
3a
Part 3a
110
3a
0
AS
VS
VD
(s)
1.0
ECG
Audio
Pressures
20
(mm Hg)
PAP
PAP
a c
0
a c
RAP
RAP
RVP
RVP
Legend:
PAP pulmonary artery pressure
RAP right atrial pressure
Time
PVC
TVC
TVO
Figure 87. Intravascular pressure waveforms on the right side of the heart during pulmonary artery catheterisation. Adapted from: C. G. Caro, T. J. Pedioy, R. C. Schroter &
W. A. Seed, The Mechanics of Circulation, OUP, 1978.
111
3a
Part 3a
After a further 510 cm, the balloon occludes the pulmonary artery and a
continuous column of blood should exist between the catheter tip and the left
atrium. A pressure trace now recorded is the pulmonary artery occlusion
pressure (wedge pressure). This corresponds to left atrial pressure and left
ventricular filling pressure, provided the following conditions are fulfilled
r The pulmonary intravascular pressure exceeds extravascular pressure, to
obtain a continuous column of blood. This condition is not fulfilled if the
intravascular pressure is low, e.g. when the catheter is lodged in West
zone 1, or if the extravascular pressure is abnormally high, as with the
application of positive end-expiratory pressure.
r The pressure in the left atrium reflects the left ventricular end-diastolic
pressure (LVEDP). In mitral valve disease left atrial pressure can be much
higher than LVEDP. Conversely, in heart failure when sinus rhythm is
preserved, LVEDP may be higher than the mean left atrial pressure: left
atrial pressure increases to the high ventricular level only during the atrial
systole.
Wedging of the pulmonary artery flotation catheter can be seen on the screen as
a sudden decrease in the amplitude of the pressure waveform to < 12 mmHg.
(Left heart filling pressure is higher than on the right side.) On deflation of
the balloon, a normal pulmonary artery trace should be seen again.
Arterial pressure waveform is shown in Figure 88 with airway pressure
during intermittent positive pressure ventilation. Blood pressure trace shows
changes in phase with respiration, called the respiratory swing. (For more
details of the effects of intermittent positive pressure ventilation on blood
pressure see next chapter.) As the intrathoraic pressure is only increased briefly
during inspiration, overall effect is a decrease in arterial systolic and diastolic
pressure which lags behind the increase in intrathroacic pressure. Respiratory
swing is pronounced in hypovolaemia, and is a valuable tool in the estimation
of fluid deficit. Notice also that the dicrotic notch is low and the arterial
pressure trace is narrow in hypovolaemia. Many ITU monitors have different
sweep speeds for arterial pressure and for respiration; association of blood
pressure swing and airway pressure is then not observed on the monitor.
112
3a
Airway
pressure
Arterial
blood pressure
113
3a
Part 3a
Cardiovascular effects of
intermittent positive pressure
ventilation
Intermittent positive pressure ventilation causes changes in intrathoracic pressure and blood volume, which are reflected in the cardiovascular parameters.
Four phases can be recognized (see Figure 89):
r Phase I: blood is forced into the left atrium by the increased intrathoracic
pressure blood pressure rises and reflex bradycardia follows.
r Phase IIa: blood pressure falls because of decreased venous return the
result of the raised intrathoracic pressure.
r Phase IIb: blood pressure is restored to normal by reflex tachycardia.
r Phase III: venous return is decreased on lowering the intrathoracic
pressure as there is now increased venous capacity in the lungs. Blood
pressure falls initially but normalizes soon as reflex tachycardia persists.
r Phase IV: persisting tachycardia results in an overshoot of blood
pressure; heart rate then drops back to normal (baroreceptor reflex) and
blood pressure then also normalizes.
The magnitude of the effect on blood pressure as a result of effects on right
and left ventricular filling depends on blood volume and the integrity of
the sympathetic nervous system control, i.e. effects will be exaggerated in
the presence of hypovolaemia, sympathetic blockade (this includes general
anaesthesia) or autonomic dysfunction (e.g. diabetic neuropathy), or a combination of factors (ill patients, e.g. sepsis), as compensation is lost (blocked
Valsalva). The ventilator settings also play a role fast ventilation rates with a
long inspiratory phase will allow little time for compensation; high ventilation
pressures will cause greater effects.
In patients with pulmonary hypertension (e.g. severe ARDS), increased
airway pressure during intermittent positive pressure ventilation results in
increased pulmonary vascular resistance. Interventricular septum may shift
to the left and compromise the left ventricular filling, and eventually decrease
the stroke volume. Because the lung is leaky in ARDS, inspiration pressure
has to be controlled rather than fluids administered to improve left ventricular
filling.
114
3a
DP 80
P 40
Figure 89. Arterial blood pressure and pulse during the Valsalva manoeuvre. SP, DP
systolic and diastolic pressures. P pulse.
SP 120
115
3a
Part 3a
116
3a
Control of cardiac output, regulation of cardiac function
100
OP
SV
50
(ml)
0
0
10
20
LVEDP (mmHg)
Figure 90. FrankStarling curves. Changes in afterload and inotropy shift the Frank
Starling curve up or down.
117
3a
Part 3a
118
3a
100
High elastance
Normal
100
200
LVEDV (ml)
Figure 91. The relationship between left ventricular end-diastolic volume and enddiastolic pressure.
LVEDP
(mm Hg)
119
3a
Part 3a
120
Pressurevolume loops
This is a dynamic representation of the relationship between left ventricular
volume and left ventricular pressure during each phase of the cardiac cycle.
The pressure volume loop can be used to describe cardiac performance
and the effect of various changes in physiological parameters.
Starting from the ED (end-diastole) point in Figure 92(a), the left ventricle
is filled to maximum and the ventricular systole starts. During the isovolumetric phase of the systole, tension develops in the muscle fibre which
will relate to the force of contraction in the next phase. Ventricular volume
during this phase remains unchanged.
During the isotonic phase of the systole, cardiac muscle contracts, i.e.
fibre shortening occurs. The aortic valve opens and blood is ejected out of
the ventricle. Ventricular pressure during this phase changes little until the ES
(end-systolic) point, when it decrases abruptly as the ventricle relaxes during
the isometric phase of the diastole.
The tangential line at the ES point describes the end-systolic pressure
volume relationship (ESPVR). Its slope corresponds to the inotropic state
of the heart (see below).
The bottom line describes the pressurevolume relationship during the
isotonic phase of diastole (ventricular filling). Its slope inversely relates to a
particular state of ventricular compliance.
Figure 92b shows how the pressurevolume loop changes with an
increased state of inotropy. Notice that the slope of the ESPVR is
steeper, allowing the ventricle to contract more forcefully and therefore to
increase the stroke volume (the difference between ES and ED point). The
ES point therefore is lower on the x-axis (LV volume).
Figure 94c demonstrates the effect of heart failure. The slope of the
ESPVR is lower, and the ventricle has to operate at a much higher filling
volume in order to generate pressures comparable to normal conditions. As
emptying is inefficient, stroke volume is smaller and the ES point is much
higher on the x-axis.
In acute heart failure due to myocardical depression such as occurs in
septic shock, the heart has a relative lack of inotropic drive. The remedy in
this case is to use inotropic infusion in order to improve the ESPVR and
enable to ventricle to contract more efficiently. The loop will shift to the left
(normal).
By contrast, the efficiency of the heart in chronic heart failure or in states of
high afterload can be improved by a decrease in afterload. This improves the
slope of the FrankStarling curve (see chapter Control of cardiac function),
which improves the stroke volume for a given ventricular filling pressure.
Thus the ES point and the whole loop moves left, and the ESPVR improves
as a result.
(a)
200
3a
ES
100
ED
100
200
LV volume (ml)
(b)
200
Increased
Inotropy
LV
pressure 100
(mmHg)
LV
pressure
(mm Hg)
Control
Loop
0
0
100
LV volume (ml)
200
Figure 92(b). The effect of increased inotropy on left ventricular pressurevolume loop.
Heart rate and aortic pressure held constant.
(c)
200
Loss of
Inotropy
LV
pressure
100
(mm Hg)
Control
Loop
0
0
100
LV volume (ml)
200
Figure 92(c). The effect of left ventricular failure (reduced inotropy) on left ventricular
pressurevolume loop. Heart rate unchanged.
121
3a
Part 3a
122
3a
Blood pressure and blood volume relationship
Sy
Me
Di
Pu
He
Ur
Re
Di
Figure 93. Changes in physiological parameters with blood loss (classes of haemorrhage).
123
3a
Part 3a
Normal cerebral blood flow is 54 ml/100g/min (750 ml/min). The formula for
flow indicates that flow is given by the ratio of pressure gradient (in this case
cerebral perfusion pressure, which is the difference between mean arterial
pressure and intracranial pressure), and resistance
MAP ICP
.
(1)
R
Autoregulation exists to maintain, within physiological limits, a constant
blood flow to the brain regardless of variations in arterial blood pressure and
intracranial pressure; this is done by changes in cerebrovascular resistance,
or by changing the perfusion pressure. As shown below, these factors are
interrelated.
r Mean arterial pressure: Figure 94 shows how autoregulation maintains
Q = p/R =
124
3a
Cerebral blood flow
No
Hy
Hy
V
p
V
p
V
Figure 95. Cerebral elastance curve.
125
3a
Part 3a
126
3a
Cerebral blood flow
per min)
Figure 96. Autoregulation of cerebral blood flow within physiological limits; it is abolished by hypercapnia.
(PaCO2)
(PaO2)
(PaCO2)
(PaO2)
Figure 97. Cerebral blood flow as a function of arterial carbon dioxide tension (Pa CO2 )
and oxygen tension (Pa O2 ).
127
3a
Part 3a
128
Coronary circulation
Myocardial blood flow is 200 ml/min, or 4% of cardiac output, for an organ
weighing only 0.4% of body weight. Oxygen consumption of the heart is also
high, 23 ml/min, or 9% of total. This is for a good reason: the heart is a pump
that perfuses the rest of the body; its work is hard and it needs a constant
energy supply from aerobic metabolism.
The coronary arteries are the first to receive oxygenated blood from the
aorta; their perfusion depends on the pressure gradient generated by
the heart. It is important to remember that coronary arteries run on the
epicardial surface. The coronary arterial pressure gradient is thus from epicardium to endocardium, while the intramural pressure gradient during systole is in the opposite direction. Therefore, there is practically no endocardial
flow during systole (see Figure 98 where coronary artery flow is plotted against
the arterial pressure waveform) while the flow in epicardium is maintained.
To compensate for the lack of perfusion in systole the subendocardial arteries
are thought to be in a chronic state of dilation during diastole. At times of
increased demand for perfusion, e.g. tachycardia, hypertension, this region
is then unable to increase flow further and thus it is more susceptible to
ischaemia.
Anaesthetic agents depress myocardial performance and oxygen consumption falls in line with reduced myocardial work (see Figure 100). Coronary blood flow therefore is reduced.
Myocardial ischaemia occurs when myocardial oxygen demand exceeds
supply, i.e. when coronary blood flow and oxygen flow fall below the minimum required. In a diseased myocardium symptoms of ischaemia occur at a
higher perfusion pressure, inside the lower limit of autoregulation. The prediction of cardiac events during anaesthesia is difficult but prevention should
be practised: cardiac performance (power) is the product of mean arterial
blood pressure and cardiac output. The output is the product of stroke volume
and heart rate. Stroke volume is not easily assessed by bedside (or operating
tableside) measurements but heart rate and blood pressure are monitored.
Thus the ratepressure product remains a useful clinical tool when estimating myocardial oxygen demand, and therapeutic manoeuvres can be directed
at optimizing myocardial performance to maintain oxygen flow to the systemic circulation (which requires adequate cardiac output and haemoglobin
concentration) while not overloading the heart by excessive pressures and
rates.
3a
Coronary circulation
129
3a
Part 3a
130
Autoregulation
Unlike the brain, which at times of need receives a higher perfusion pressure
via baroreceptor stimulation, the heart cannot effectively increase its oxygen
flow by increasing its perfusion pressure since the heart generates the pressure:
myocardial oxygen consumption rises proportionately with myocardial work.
The heart, therefore, regulates its perfusion only via changes in coronary artery
resistance. The oxygen tension in the myocardium or a related parameter is
the governing factor. Autoregulation maintains a constant blood flow in the
coronary circulation within a wide range of pressures, 60140 mmHg (see
Figure 99). It must be kept in mind that the aortic diastolic pressure (not the
mean arterial pressure) is the coronary perfusion pressure.
The sympathetic and parasympathetic nervous system affects the
coronary vascular resistance, but this is modified by autoregulation: adrenergic stimulation produces coronary vasoconstriction but if coronary
blood flow is compromised autoregulation results in vasodilatation. Parasympathetic stimulation, if unopposed, results in bradycardia. The accompanying
fall in oxygen demand produces vasoconstriction; however, if a fast heart rate
is maintained, vasodilatation prevails.
3a
Coronary circulation
f
Figure 100. Effect of inhalational anaesthesia with halothane on coronary blood flow
and myocardial oxygen consumption.
131
Part 3b
133
Oxyhaemoglobin dissociation
curve
3b
Part 3b
r
r
r
For ease of O2 delivery to the tissues, oxygen should bind easily to haemoglobin in the lung, and it should be easily released in the periphery.
134
3b
A
t, [H+], pCO2, 2,3DPG
75
50
25
pso
10
SO2(%)
100
pO2(kPa)
The body normally tends towards acidosis, constantly produces CO2 and
produces heat. These conditions result in a lower affinity of haemoglobin for
O2 , to facilitate O2 release in the tissues. The price for this is the necessary
higher O2 partial pressure that must be supplied. Conversely, to achieve adequate oxygen delivery, fetal haemoglobin must have a higher affinity than
maternal haemoglobin for O2 . The fetal pH range is lower than maternal pH
and this allows O2 to be released in the fetal tissues.
135
3b
Part 3b
136
3b
(b)
p A
p A
p A
Figure 102. Respiratory mechanisms. (a) resting position of the isolated lung and chest
(right lung) and resting expiratory position of the normal lung at FRC (left lung). Atmospheric pressure p = A. Pressure gradients are shown as vectors, (b) pressure gradients
after a tidal breath.
C
C
(a)
p
Figure 103. Static compliance of the lung (CL ), chest wall (CCW ) and total compliance
(CT ).
137
3b
Part 3b
which means that total thoracic compliance is smaller than that each component. It is the stiffness of each that adds up directly. Therefore, to expand the
thorax by 500 ml, a pressure difference of 5 cm has to be applied.
The volumepressure relationship of the lungs and chest wall are not
linear at the extremes of lung volume: at a high lung volume the lung opposes
further filling, i.e. its compliance is smaller (compliance slope less steep). In
Figure 103, the compliance is the slope of the line depicting the pressurevolume relationship. At a low lung volume below the resting expiratory level,
the expansile force of the chest opposes further expiration, so that chest wall
compliance is smaller. This is reflected in the shape of each compliance curve.
Notice that the total compliance then becomes a sigmoid curve. The nonlinearity should be kept in mind when comparing different compliances: the
pressure difference for each value should be stated.
Factors affecting compliance are:
r Disease: in atelectasis, when the lung is relatively stiff, the point of
138
3b
C
C
Figure 104. The effect of age on lung compliance (CL ) and chest wall compliance (CCW ).
139
3b
Part 3b
140
Airways closure
Pleural pressure is influenced by the pressure of thoracic contents: it is less
subatmospheric in the dependent lung zones then in the apex. When a normal
subject exhales below the resting expiratory level, and towards the residual
volume, pleural pressure eventually approaches or exceeds atmospheric pressure. The pressure gradient distending the small airways is thus lost, and the
small airways will close; they will re-open only when a sufficient gradient is
reached for their distension. The lung volume at which the airways close is
called the closing volume. It increases more rapidly with age than the functional residual capacity. At around 65 years of age closing volume exceeds
the FRC and airway closure occurs then during tidal breathing. The resulting mismatching of ventilation and perfusion is the explanation for the
higher shunt fraction in the elderly. The relationship of closing volume and
FRC is shown in Figure 105 for the upright and supine positions, and for the
supine-anaesthetized patient. The further the closing volume line from the
FRC line at a given age, the higher the shunt fraction. (See also the chapter
on ventilationperfusion relationship.)
3b
Age
Figure 105. Changes in closing volume (CV) and functional residual capacity (FRC)
during adulthood.
141
3b
Part 3b
r
r
r
r
142
3b
Respiratory mechanics 2: Dynamic properties, factors affecting resistance
Diameter
Order
Figure 106. Size of airway and total cross-sectional area.
Age
Figure 107. Airway resistance (R) and age.
143
3b
Part 3b
144
Dynamic compliance
This is measured during normal tidal breathing. Figure 108 shows the plot of
lung volumes and pressures for two sizes of breath in the normal lung, and
a large breath in chronic obstructive airways disease. The slope of the axis
of each loop is identical with the static compliance. It can be seen that for
a normal (tidal) breath in the normal lung, the compliance slope is steeper
than for a large breath, i.e. the lung is more compliant during normal tidal
breathing than during a vital capacity breath. During a vital capacity breath
in chronic obstructive airways disease, compliance slope is identical to the
normal lung (or it could be higher if the disease progresses to emphysema)
but the loop encompasses a greater area, indicating a greater work of breathing
(see chapter on simple mechanics, work and power). This is understandable
as the work is done against a higher airways resistance.
3b
Small
and
e.
Large
and
e.
Large
airways
e.
145
3b
Part 3b
146
Ventilationperfusion relationship
Alveolar ventilation and its distribution
Approximately two-thirds of total ventilation reach the alveoli; one-third
remains in the bronchi and is not available for gas exchange dead space gas.
Fresh gas that enters the alveoli per minute is known as alveolar ventilation;
the normal value is about 5 l min1 .
Alveolar ventilation is not distributed evenly in the lung: dependent regions
are better ventilated during spontaneous respiration than the upper zones.
This is because of the effects of gravity: pleural pressure at the base is less
negative, and the alveoli at the base are less expanded than apical alveoli. In
Figure 109, apical alveolus, represented by point A, is already nearly 80%
expanded, while the basal alveolus at point B is only about 30% expanded. At
maximum inspiration the change of size is higher for the basal alveoli than
the apical ones, which had less scope for expansion. The above only applies
for the normal lung at normal lung volumes. If basal alveoli are collapsed they
receive no ventilation if the tidal breath, and the pleural pressure change is
small. This is illustrated by point C (closed alveolus) in Figure 109. Such a situation occurs in the normal lung at residual volume, in old age when closing
volume exceeds functional residual capacity or in chronic obstructive airways
disease when functional residual capacity is high and the tidal breathing range
is near the closing volume. Pleural pressure at the lung base exceeds atmospheric pressure in these situations, and a greater change in pressure gradient
is required to re-expand basal alveoli, as shown.
Figure 110 illustrates how alveolar size changes across the lung from apex
to base.
3b
p
Figure 109. Lung pressurevolume diagram in a young, healthy adult.
Ventilationperfusion relationship
147
3b
Part 3b
148
3b
Pressure gradients
Ventilationperfusion relationship
West zone
149
3b
Part 3b
150
Ventilationperfusion ratio
Blood flow increases more rapidly with the distance from apex in the upright
lung than ventilation. Blood flow at the base is 20 times higher than blood
flow at apex, while basal ventilation is only three times higher than apical ventilation. As a consequence the ventilation/perfusion ratio (V/Q) diminishes
from apex to base, to about 15% of the apical value at base. In other words, the
apex is relatively over ventilated while the base is relatively over perfused.
This is the basis of the physiological ventilation/perfusion inequality.
Figure 112 illustrates this schematically. Ventilation of unperfused alveoli
at the apex contributes to the physiological dead space effect, as mentioned above: inhaled fresh gas is wasted and is unavailable for gas exchange.
Perfusion of unventilated alveoli at the base means that blood flowing through
this region will receive no oxygen, and will contribute to the physiological
shunt. In the normal lung the base receives most of the pulmonary blood
flow; as the blood there is less well oxygenated, the result is a venous admixture, normally up to 5%. Well ventilated but under perfused apical regions
cannot compensate for the shunt by increasing oxygenation of the blood
that they receive, as the blood is already fully saturated with oxygen; this is due
to the shape of oxygen dissociation curve. Carbon dioxide exchange, however, is a linear function of its partial pressure; apical alveoli can compensate
to a large extent for the excess CO2 arising from the non-ventilated basal
alveoli. Thus end-tidal (alveolar) to arterial gradient for CO2 is < 1 mmHg,
or 0.13 kPa, while the end-tidal to arterial gradient for O2 is several mmHg.
Increased total ventilation of a normal lung can compensate for both, as the
basal well-perfused alveoli will then receive more ventilation.
During anaesthesia changes in dead space and shunt fraction occur: as
shown previously, closing volume is above functional residual capacity in most
anaesthetized patents. Endobronchial intubation increases the shunt fraction
substantially (one lung perfused but not ventilated). A higher inspired oxygen
concentration can only partly compensate for this. Dead space changes follow
changes in cardiac output, e.g. hypotension.
3b
e.
D
Air
e.
De
d.
e.
Blood
Ox
d.
Ventilationperfusion relationship
Air
151
3b
Part 3b
152
3b
20
15
E
A
10
c
5
m
I = inspired (warmed humidified) air.
E = end-expiratory gas.
A = ideal alveolar gas.
a = arterial blood.
c = mean capilary blood.
m = mitochondria.
pO2 (kPa)
153
3b
Part 3b
154
3b
Oxygen cascade, oxygen therapy and shunt fraction
paO2
Pa
v
fi O2
Figure 114. The effect of shunt function and inspired oxygen fraction (fi O2 ) on arterial
oxygen (pa O2 ). Assumptions as above are made.
155
3b
Part 3b
E),
VDanat = anatomical dead space (points E
`
VDphys = physiological dead space (points AE),
156
or, in other words, the ratio of dead space ventilation to total ventilation is the
same as the ratio of the difference between partial pressures of CO2 in arterial
3b
V
p
V
p
157
3b
blood and the expired gas to arterial p CO2 . Another variant of this equation
is:
Part 3b
2
or, in other words, the ratio of alveolar dead space to total ventilation is the
same as the ratio of the arterial end-tidal pressure gradient for CO2 to arterial
p CO2 . The nominator in the equation, the arterial to end-tidal pressure
gradient for CO2 , is easily measured and serves to assess the magnitude of
dead space.
The ideal alveolar oxygen tension is calculated from the Nunn equation.
Notice that point X is not zero as alveolar pO2 is not zero; therefore pAO2 has
to be subtracted from the values on the horizontal axis:
IX/IX = AI/EI,
therefore
p iO2 p AO2 / p iO2 p EO
2 = p aCO2 / p EO
2.
All gas tensions, except pAO2 , can be measured. Then
),
p AO2 = p iO2 paCO2 ( p iO2 = p EO
2 / p ECO
2
where p iO2 and p EO
2 are measured directly by the paramagnetic oxygen analyser (or any of the other oxygen analysis methods), p aCO2 is measured directly
from arterial blood sample and p ECO
is measured in expired gas collected into
2
a Douglas bag, with an infrared CO2 analyser.
The Nunn equation is used for the calculation of the alveolar p O2 , which
is then used in the calculation of the shunt fraction, not derived here.
Qs /Qt = c c c a /c c c v ,
where c is oxygen content, and the subscripts are c for end-pulmonary capillary, a for arterial and v more mixed venous blood. Arterial and mixed venous
oxygen content is measured directly by the Van Slyke method or any of the
other oxygen analysis methods; mixed venous blood is sampled from the pulmonary artery catheter. End-pulmonary capillary blood cannot be sampled
but oxygen tension in the pulmonary capillary is assumed to be in equilibrium with alveolar oxygen tension, derived from the Nunn equation. Oxygen content in the pulmonary capillary is then calculated from the saturation,
assuming a normal oxyhaemoglobin dissociation curve.
158
3b
Gas R line, solution of the ventilation/perfusion model
159
3b
Part 3b
160
3b
Ventilatory response to oxygen
M V(l min1)
30
20
10
8
70
12
80
16 paO2 (kPa)
90 SaO2 (%)
161
3b
Part 3b
162
3b
Ventilatory response to carbon dioxide
MV
(% of normal)
500
400
300
200
100
10
20
30
40
paCO2 (kPa)
163
Part 4
Pharmacology
165
Drug elimination
Part 4
Cl/V
Al
Drug elimination
dc dt
Re
c
Figure 118. First-order kinetics of remifentanil and alfentanil.
Zero
First
Time
dc dt
c
Figure 119. Zero-order and first-order elimination of blood alcohol from 1 mg1 to
complete elimination.
167
4
Part 4
168
4
Drug elimination
Time
169
4
Part 4
170
4
Uptake and distribution of inhalational anaesthetic agents
Figure 121. Factors influencing alveolar gas or vapour concentration during uptake.
171
4
Part 4
172
4
N2O
Sevoflurane
1.0
Isoflurane
Halothane
0.5
10
20
30
40
50
t (min)
Figure 122. Rate of rise of alveolar concentration for different anaesthetic agents.
fA /fi
173
Part 4
Most but not all drugs produce their effects by binding to receptor sites. When
an active drug binds to its receptor site, the receptor changes its configuration
to its active state, and this initiates an intracellular response in the effector
tissue, and eventually results in the drugs effect.
This binding is reversible, with an equilibrium that depends on the association and dissociation constants of the process.
Drug + receptor
k1
k2
Doseresponse curve
The doseresponse curve is the plot of the dose of a drug against its effect,
usually expressed as the percentage of maximum effect. Initially, the effect
rises steeply up to 50%; thereafter, progress to the maximum effect is slower,
with much higher doses required to produce the ceiling effect. The graphical
result is a rectangular hyperbola (Figure 123), conforming to the formula
y = a 1/x.
If the graph is re-plotted with log dose on the ordinate, the result is a sigmoid
shape. This has advantages: it allows a greater range of doses to be represented,
and it allows easy comparison of drug dosages on the straight part of the curve
by the means of comparing their efficacy and potency. To produce an effect,
a drug has to bind to the receptor site; its affinity for the receptor therefore
affects both its efficacy and its potency. These terms are explained below.
Affinity
Affinity is a measure of the ability of a drug to bind to the receptor site and
form a stable complex. Pure agonist drugs have a high affinity for the active
state of the receptor, whereas pure antagonists have a high affinity for its
inactive state. Thus, drugs with a high affinity for the same receptor can
have very different effects, depending on their intrinsic activity, or efficacy
(see below). Affinity may be expressed by an IC50 , which is the concentration
producing 50% inhibition of the binding of a highly selective ligand. Among
agonist drugs, there is a high correlation between their IC50 and their potency.
The relationship between affinity and efficacy is not only complicated by the
degree of agonism, as mentioned above, but also by other limiting factors that
may be involved in the process of the biological response, e.g. the presence of
other ligands, second messengers, etc. A well-known example is the degree
of acetylcholine receptor occupancy by non-depolarizing relaxants versus the
degree of neuromuscular block.
174
4
Pharmacodynamic effects of drugs
175
Part 4
The maximum effect that a drug is capable of producing is its efficacy, i.e. it is
the plateau of the doseresponse curve; in other words, efficacy indicates
the limit of the doseresponse relationship on the y (effect)-axis.
Pure agonists have a high affinity for the active state of the receptor site
(e.g. morphine and the receptor), and are 100% efficacious. Antagonist
drugs (e.g. naloxone and the receptor) have no intrinsic activity (they have
a high affinity for the inactive state of the receptor site), and are not efficacious. Partial agonists (e.g. nalorphine and the receptor, -adrenergic
blockers with intrinsic sympathomimetic activity and the -adrenergic receptor) have only low affinity for the active receptor site, so that even at maximum
receptor occupancy not all receptor sites will be activated. Therefore, partial
agonists have a lower intrinsic activity or efficacy < 100%. Full and partial
agonist opioid log doseresponse curves are shown in Figure 124; the plot for
naloxone is identical with the x-axis. Buprenorphine and nalorphine have not
only lower affinity than fentanyl but also a lower efficacy than all three full
agonists they do not achieve 100% response.
Potency
The potency of a drug is a measure of the mass of the drug required to
produce a certain level of effect. Clearly it is not useful to chose 100%
effect as the doseresponse relationship is lost at that level. A reference
point on the doseresponse curve is therefore chosen to allow a comparison,
usually 50% of the maximum effect. A drug that produces the same (50%)
effect with only 1/10th of the dose (mass) of another drug is 10 times more
potent (e.g. pethidine and morphine). Relative potency of morphine versus
pethidine is therefore 10, calculated as the ratio of equipotent doses. Potency
can be illustrated as the position of the log doseresponse curve along the
x (dose)-axis; the less potent a drug, the further its doseresponse curve lies
along the x-axis (Figure 124).
Antagonism
Competitive antagonists
Competitive antagonists occupy reversibly some of the available receptor
sites; if a higher dose of active drug is given, it can still achieve its maximum
effect. Competitive agonists, therefore, in effect reduce the potencyof a
drug, but not its efficacy (the doseresponse curve shifts along the x-axis,
the shape is unchanged). Naloxone reversibly antagonizes opioid drugs; in
its presence the log doseresponse curves are shifted to the right, as shown
opposite on the example of pethidine.
176
Bu
Mo
Al
Pe
Pe
Na
Na
100
Fe
177
4
Part 4
Non-competitive antagonists
Non-competitive antagonists bind irreversibly to the receptor sites; thus they
make some (or all) of the receptor sites unavailable to the active drug. Increasing the dose of the active drug does not achieve a full effect. Non-competitive
antagonists thus reduce the efficacy of a drug, while its potency, at least
in the lower part of the curve, is relatively unchanged. The picture produced is the same as that of partial agonist drugs. In Figure 125, compare the
log doseresponse curve of norepinephrine under normal conditions, in the
presence of a competitive blocker (phentolamine) and in non-competitive
antagonism by increasing doses of phenoxybenzamine.
To quantify the degree of partial agonism by various agonists, pA2 has been
devised. This is the negative logarithm of the concentration of the antagonist
necessary to produce a particular level of response. Thus, pure agonists at
one type of opioid receptor, such as (morphine, -endorphine) have the
same pA2 for naloxone (7), while pA2 for leu-enkephalin is about 6. In other
words, ten times more naloxone is needed to antagonise the effects of leuenkephalin than to antagonize -endorphine. (Remember that a difference of
1 unit on the logarithmic scale is ten times the difference on the linear scale.)
This suggests that these two agents act on different receptor populations,
an observation which was postulated even before the receptor (at which
leu-enkephalin is an agonist) was isolated.
Therapeutic index
The therapeutic index is a measure of the safety of a drug in clinical use.
Reference points on two integrated probability curves (otherwise known as
centile curves) need be compared; one for a desired clinical effect, the other
for a toxic effect. The centile curve resembles the log doseresponse curve but
is different: the y-axis represents the percentage of population that responds at
the given dose; the x-axis scale is linear, as shown in Figure 126. The reference
point is a dose that produces the chosen effect in 50% of the individuals. ED50
is the median effective dose (which produces the clinical effect in 50% of the
population, whether human or experimental animal), and LD50 is the median
lethal dose (which produces death in 50% of experimental animals). The ratio
LD50 /ED50 is the therapeutic index. Drugs that are relatively non-toxic have
a high therapeutic index (LD50 much higher than ED50 ), while the reverse
is true of the more toxic drugs, such as digoxin (LD50 closer to ED50 ). The
slope of the doseresponse curve is usually an indicator of the drugs toxicity
the lower the therapeutic index, the more steep the rise of the slope. In the
example opposite, LD50 is about ten times higher than ED50 ; the therapeutic
index is sufficiently large.
178
4
Pharmacodynamic effects of drugs
Ph
No
Ph
Log dose
of norepinephrine
Figure 125. Competitive and non-competitive antagonism of norepinephrine effect on
log doseresponse curve.
po
De
De
Do
Figure 126. ED50 , LD50 .
179
4
Part 4
180
4
Minimum alveolar concentration and lipid solubility
Figure 127. MAC and lipid solubility of volatile agents in 100% oxygen and in 66%
nitrous oxide.
181
4
Part 4
182
Extracellular space
Cell
Intracellular space
(b)
(a)
Extracellular space
Cell
Intracellular space
183
4
Part 4
184
4
Extracellular space
Cell
Catalysis
Figure 130. Receptor as enzyme.
Intracellular space
Ligand
185
4
Part 4
186
Context-sensitive half-time
This concept was developed to describe drug elimination after an intravenous
infusion, designed to produce a steady plasma concentration of a drug, is discontinued. Drugs which depend on the liver or kidneys for their elimination
demonstrate this phenomenon. In practice, this encompasses all hypnotic
drugs and opioids used in total intravenous anaesthesia, with the exception of
remifentanil, which is eliminated from the body by tissue and plasma esterases.
Half-time is the time required for the drug concentration to halve. Recovery
cannot be expected before the plasma concentration decreases below 50% or
the clinically effective concentration.
The half-time is context sensitive because drug elimination depends on
the duration of infusion. To understand it, consider the three-compartment
pharmacological model, consisting of the central compartment-C1 -(the
intravascular space) and two peripheral compartments, one which equilibrates with the central compartment fairly rapidly-C2 -(well perfused tissues
such as the brain) and the other which equilibrates more slowly because of
poorer perfusion-C3 -(fat). The rich or poor perfusion is illustrated in the
figures opposite by a wide or narrow band connecting the compartments.
After a short duration infusion, the peripheral compartments have not
yet reached equilibrium with the central compartment (see Figure 131).
Therefore, after the infusion is discontinued, plasma concentration declines
fairly rapidly as the drug continues to redistribute into the peripheral compartments, until equilibrium is reached at a lower plasma concentration. Because
redistribution is faster that elimination, context-sensitive half-time in this
situation is closer to the redistribution half-life.
After a prolonged infusion, the peripheral compartments reached equilibrium with the central compartment and drug concentration is the same in
all three (steady state), as shown in Figure 132. On discontinuing the infusion,
plasma concentration can only decline by drug elimination from the central
compartment via liver or kidneys. As the drug is being eliminated, more drug
is moved from the peripheral compartments into the central compartment,
adding to the drug load to be eliminated. Hence the context-sensitive halftime in this situation is close to elimination half-life.
4
C3
C1
K10
Elimination
Context-sensitive half-time
C2
C1 central compartment
C2,C3 peripheral compartments
Figure 131. Drug levels in three compartments after a short infusion.
C2
C3
C1
K10
Elimination
Figure 132. Drug levels in three compartments after a prolonged infusion.
187
4
Part 4
188
100
10
10
20
30
40
t (min)
Figure 133. Plasma alfentanil concentration after short and long infusion.
CSHT
(min) 50
Context-sensitive half-time
3-hour infusion
10-min infusion
C
(mg/ml)
50
Thiopentone
Alfentanil
Fentanyl
Propofol
Remifentanil
10
10
20 30 40 50
Fentanyl
CSHT
(min)
200
Thiopentone
100
Alfentanil
Propofol
Remifentanil
1
2
3
4
5
6
Duration of infusion (hrs)
189
4
Part 4
190
Further Reading
Kenny, G., Davis, P. D. Basic Physics and Measurement in Anaesthesia. Butterworth Heinemann,
2003.
Miller, R. D. Anaesthesia. Edinburgh: Churchill Livingstone, 2000.
Peck, T. E., Williams, M. Pharmacology for Anaesthesia and Intensive Care. Greenwich Medical
Media, 2000.
Mepleson, W. W. Fifty years after reflections on The elimination of rebreathing in various
semi-closed anaesthetic systems. Br. J. Anaesth. 2004; 93: 31921.
Pinnock, C., Lim, T., Smith, T. Fundamentals of Anaesthesia. Greenwich Medical Media, 2002.
Prys-Roberts, C. The Circulation in Anaesthesia. Oxford: Blackwell, 1980.
Scurr, C., Feldman, S. Scientific Foundations of Anaesthesia. Oxford: Butterworth-Heinemann.
www.frca.co.uk.
INDEX
Page references in italic indicate figures.
abscissa (x-axis) 26
absorption system see circle system
acid, hydrogen ion concentration 92
acidbase balance 92, 93, 94, 95
acidosis 92
adiabatic compression and decompression 6,
7
adrenergic receptor (adenyl cyclase) 184
age effects
airway resistance 144, 145
airways closing volume 142, 143
thoracic compliance 140, 141
agonist drugs 176, 178, 179, 180
air, saturation with water vapour 16, 17
airway diameter, and airway resistance 144,
145
airway resistance (non-elastic), factors
affecting 144, 145
airways closure (closing volume) 142, 143
alcohol, rate of elimination 168, 169
alfentanil 179
context-sensitive half-time 190, 191
effects of duration of infusion 190, 191
elimination rate constant 168, 169
alkali, hydrogen ion concentration 92
alkalosis 92
alveolar oxygen tension 154, 155
alveolar partial pressure of O2 158, 159, 160
alveolar pressure, calculation 64
alveolar size, changes from lung apex to base
148, 149
alveolar ventilation and its distribution 148,
149
amplitude (sine waves) 28
amplitude distortion 68, 70
anaesthesia
changes in lung dead space 152
effects of IPPV 114
effects on airway resistance 144
effects on airways closing volume 142, 143
effects on hypoxic ventilatory response
162
effects on left ventricular compliance 118
effects on myocardial performance 129,
131
effects on thoracic compliance 140
191
Index
192
barotrauma 52, 64
baseline drift 68, 69, 70
bimodal distribution 42, 43
blood donation, compensatory responses
122
blood flow
in the lung 150, 151
measurement 96, 97, 98, 99
blood flow autoregulation
cerebral blood flow, 124, 125, 126, 127
perfusion of the heart 129, 130
responses to blood loss 122, 123
blood gas analysers 80, 81, 82, 83, 84
blood loss 122, 123
blood oxygen saturation measurement 76, 77,
78, 79
blood pressure
and blood volume 122, 123
respiratory swing 112, 113
blood pressure measurement,
electromanometer 72, 73, 74, 75
blood viscosity, and cerebral blood flow 126
blood volume
and blood pressure 122, 123
and effects of IPPV 114
body size, and airway resistance 144
Bohr equation 158, 159, 160
Boyles law 2, 3, 26
breathing
loss of water and heat 16, 17
turbulent flow 12
breathing systems
circle system 54, 55, 56, 57
Mapleson A (Magill) system 58, 59
T-pieces 60, 61
bronchial mucosa thickness, and airway
resistance 144
bronchial muscle tone, and airway resistance
144
buprenorphine 178, 179
calibration of instruments 70
capnography 86, 87, 88, 89, 90, 91
response time 86
trend analysis 90, 91
types of capnograph 86, 87
uses 90
waveform analysis 86, 87, 88, 89
carbon dioxide (CO2 )
end-tidal concentration 26
former use in anaesthesia 164
infrared light absorbance 86
measurement (capnography) 86, 87, 88, 89,
90, 91
ventilatory response 164, 165
see also CO2 partial pressure
cardiac cycle
end-systolic pressurevolume relationship
(ESPVR) 120, 121
intravascular pressure waveforms 110, 111,
112, 113
left ventricle and systemic circulation 118
left ventricular compliance and elastance
118, 119
left ventricular volume and pressure
relationship 118, 119, 120, 121
pressurevolume loops 120, 121
pressurevolume relationships 118, 119,
120, 121
right ventricle and pulmonary circulation
118
cardiac output
heart rate 116
improving in critically ill patients 116, 117
measurement by thermal dilution method
98, 99, 1001, 101
stroke volume 116, 117
sympathetic nervous system control 116
treatment for pump failure 116
treatment for volume loss 116
cardiac performance, pressurevolume loops
120, 121
cardiac power, ways of expressing 24, 25
cardiac stroke volume
afterload 116, 117
contractility 116
FrankStarling relationship 116, 117
preload (venous return) 116, 117
relationship with LVEDP 116, 117
cardiovascular effects of IPPV 112, 113, 114,
115
central venous pressure trace 110, 111
cerebral blood flow
and partial pressure of CO2 126, 127
autoregulation 124, 125, 126, 127
cerebrovascular resistance 124, 126, 127
Cushings reflex (reflex bradycardia) 124
intracranial pressure and cerebral elastance
124, 125
mean arterial pressure 124, 125
normal range 124, 125
perfusion pressure 124, 125
responses to blood loss 122
cerebral elastance 124, 125
Charles law 2, 3
chest
airways resistance 102, 103
mechanical properties 102, 103
static compliance 102
chest wall
compliance 138, 139, 140, 141
elastic properties 138, 139, 140, 141
Index
193
Index
enflurane
lipid solubility 182, 183
MAC 182, 183
uptake 56, 57
ESPVR (end-systolic pressurevolume
relationship) 120, 121
exponential decay curve 30, 31, 36, 37, 38, 39
exponential decay process
half-life 30, 31, 38
time constant ( ) 36, 37, 38
time to finish 38
exponential growth curve 30, 31, 32, 33, 34
fentanyl 179, 190, 191
fetal haemoglobin, affinity for O2 136
first-order kinetics 168, 169, 170
flow 8
laminar 8, 9, 10, 11
turbulent 12, 13
flow measurement
gases 96, 97
liquids 96, 97, 98, 99
flow velocity
factors affecting (laminar flow) 8, 10
HagenPoiseuille equation 10
fluid deficit, and respiratory swing 112,
113
force 18, 19
Fourier analysis 28
FrankStarling relationship 116, 117, 118
FRC (functional residual capacity)
and closing volume 142, 143
measurement 104, 105, 106, 107
frequency (sine waves) 28
frequency histogram 40
frequency response (natural resonant
frequency) 72
fuel cell method (oxygen content
measurement) 82, 83, 74
194
gas laws
Boyles law 2, 3
Charles law 2, 3
GayLussacs law 2, 3
universal gas equation 2
gas pressure
decompression volume calculation 52
units of measurement and conversions 52
gas R line 158, 159, 160
gas supply, pressure/volume relationship 52,
53
gases
adiabatic compression and decompression
6, 7
critical temperature 4, 5
flow measurement 96, 97
Gaussian (normal) distribution 40, 41
GayLussacs law 2, 3
glycine receptors 184
growth factor 186
growth rate constant 30
haemoglobin
factors affecting oxygen affinity 134, 135,
136
fetal 136
light absorbances of different forms 76, 77,
78, 79
mean corpuscular concentration 134
oxyhaemoglobin dissociation curve 134,
135, 136
haemorrhage
classification of severity 122, 123
compensatory responses to 122, 123
effects of increasing severity 122, 123
HagenPoiseuille equation 10, 72, 126, 144
half-life 38
drug concentration in plasma 188, 189,
190, 191
for drug elimination 30, 31, 38
halothane
effects on coronary blood flow 131
effects on myocardial oxygen demand
131
lipid solubility 182, 183
MAC 182, 183
uptake 56, 57, 173
harmonics (sine waves) 28
head injury
cerebral perfusion pressure 126
effects on intracranial pressure 126
haematoma and/or cerebral oedema 126
hypercapnia 126, 127
hypocapnia under anaesthesia 126
loss of cerebral blood flow autoregulation
126
Index
heart
autoregulation of perfusion 129, 130
heart muscle power 24, 25
see also cardiac cycle; myocardium
heart failure
effects on pressurevolume loop 120, 121
improvement of heart function 120, 121
LVEDP 112
heat energy, and change of phase 14
helium and oxygen mixture 12
helium wash-in method, to measure FRC
104, 105
humidification 16, 17
hydrogen ion (H+ ) concentration 92, 93, 94,
95
and cerebral blood flow 126
and O2 affinity for haemoglobin 134, 135,
136
conversion to pH 92, 93
see also pH
hypercapnia 64, 90, 91, 164, 165
effects on cerebral blood flow 126, 127
effects on hypoxic ventilatory response
162
hypocapnia 90, 91
effects on cerebral blood flow 126, 127
hypotension, differential diagnosis 90
hypovolaemia
effects of IPPV 114
respiratory swing 112, 113
hypoxia 154
hypoxic ventilatory response 162, 163
hysteresis 68, 69
J-shaped distribution 42
joule (J) 22
katharometer 104
laboratory tests
false negatives 48, 49, 50, 51
false positives 48, 49, 50, 51
location of cut-off point 48, 49, 50, 51
measure of usefulness 50, 51
sensitivity 48, 49, 50, 51
specificity 48, 49, 50, 51
LambertBeer law 76
laminar flow 8, 9, 10, 11
square function 28, 29
latent heat (definition) 14
latent heat of vaporization 6, 14, 15, 16,
17
LD50 180, 181
left ventricle
and systemic circulation 118
compliance and elastance 118, 119
LVEDP (left ventricular end-diastolic
pressure) 112, 118, 119, 120, 121
LVEDV ( left ventricular end-diastolic
volume) 118, 119, 120, 121
volume and pressure relationship 118, 119,
120, 121
leu-enkephalin 180
ligand-gated ion channel 184, 185
linear relationship 26, 27
linearity principle 68, 69
lipid solubility of inhalational anaesthetic
agents 182, 183
liquefaction of compressed gas 4, 5
liquids, flow measurement 96, 97, 98, 99
log-normal distribution 42, 43
logarithm and the logarithmic curve 32, 33,
34
logarithmic scales 34
pH measurement 92, 93
lung compliance 64
195
Index
196
signal-to-noise ratio 70
static accuracy 68, 69
median (middle value) 42, 43
mitochondrial oxygen tension 154, 155
mitochondrial poisoning, tissue hypoxia 154
mitral valve disease, LVEDP 112
mode (most frequent value) 42, 43
morphine 178, 179, 180
muscarinic receptors 184
myocardium
blood flow rate 128, 131
ischaemia 129
oxygen consumption 128, 131
performance, effects of anaesthetic agents
129, 131
myogenic control of cerebrovascular tone
126
nalorphine 178, 179
naloxone 178, 179, 180
nervous system, effects on coronary vascular
resistance 130
neurogenic control of cerebrovascular tone
126
neurotropic factor 186
newton (N) 18
nicotinic receptor 184
nitrogen washout from the body 56
nitrogen washout method, to measure FRC
106, 107
nitrous oxide
adiabatic compression and decompression
6, 7
critical temperature 4
isothermic compression and
decompression 4, 5
lipid solubility 182, 183
MAC 182, 183
rate of uptake 172, 173
specific latent heat 14, 15
uptake in circle system 54, 55, 56, 57
noise (false signal) 70
non-competitive antagonists 180, 181
norepinephrine 180, 181
normal (Gaussian) distribution 40, 41
obesity, effects on thoracic compliance 140
opioid agonists and partial agonists 178, 179
opioid antagonists 178, 179
ordinate (y-axis) 26
oscillatory movement, sine waves 28, 29
oxygen
affinity for haemoglobin 134, 135, 136
alveolar partial pressure 158, 159, 160
binding to haemoglobin 80, 81, 82, 83
critical temperature 4
Index
197
Index
198
Index
199